110 related articles for article (PubMed ID: 26578182)
21. Thrombin generation with heparin-bonded cardiopulmonary bypass circuits.
Bannan S; Martin PG
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):849. PubMed ID: 8800182
[No Abstract] [Full Text] [Related]
22. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
23. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
Cankovic L; Steenwyk BL; McGiffin DC; Nielsen VG
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):725-6. PubMed ID: 18832918
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin and heparin cofactor II-mediated inactivation of alpha-thrombin by a synthetic, sulfated mannogalactan.
Gracher AH; Cipriani TR; Carbonero ER; Gorin PA; Iacomini M
Thromb Res; 2010 Sep; 126(3):e180-7. PubMed ID: 20553946
[TBL] [Abstract][Full Text] [Related]
25. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
26. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome.
Seki T; Shingu Y; Sugiki H; Wakasa S; Katoh H; Ooka T; Tachibana T; Kubota S; Matsui Y
J Artif Organs; 2018 Sep; 21(3):363-366. PubMed ID: 29541945
[TBL] [Abstract][Full Text] [Related]
28. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
29. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass.
Huyzen RJ; van Oeveren W; Wei F; Stellingwerf P; Boonstra PW; Gu YJ
Ann Thorac Surg; 1996 Aug; 62(2):533-7. PubMed ID: 8694618
[TBL] [Abstract][Full Text] [Related]
30. Heparin concentrations in neonates during cardiopulmonary bypass.
Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
[No Abstract] [Full Text] [Related]
31. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
[TBL] [Abstract][Full Text] [Related]
32. Focus on thrombin: alternative anticoagulants.
Merry AF
Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):256-60. PubMed ID: 18270188
[TBL] [Abstract][Full Text] [Related]
33. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures.
Taneja R; Cheng DC
Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205
[No Abstract] [Full Text] [Related]
34. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulation during extracorporeal circulation under conditions of an ongoing systemic inflammatory response syndrome: effects of heparin.
Feindt P; Litmathe J; Boeken U; Gams E
Perfusion; 2005 Jan; 20(1):11-5. PubMed ID: 15751665
[TBL] [Abstract][Full Text] [Related]
36. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
Levy JH
Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
[No Abstract] [Full Text] [Related]
37. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
38. Improving cardiopulmonary bypass: heparin-coated circuits.
Vocelka C; Lindley G
J Extra Corpor Technol; 2003 Dec; 35(4):312-6. PubMed ID: 14979422
[TBL] [Abstract][Full Text] [Related]
39. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
[TBL] [Abstract][Full Text] [Related]
40. [Heparin resistance during cardiopulmonary bypass].
Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
